236 related articles for article (PubMed ID: 25255287)
1. Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.
Venkataswamy MM; Ng TW; Kharkwal SS; Carreño LJ; Johnson AJ; Kunnath-Velayudhan S; Liu Z; Bittman R; Jervis PJ; Cox LR; Besra GS; Wen X; Yuan W; Tsuji M; Li X; Ho DD; Chan J; Lee S; Frothingham R; Haynes BF; Panas MW; Gillard GO; Sixsmith JD; Korioth-Schmitz B; Schmitz JE; Larsen MH; Jacobs WR; Porcelli SA
PLoS One; 2014; 9(9):e108383. PubMed ID: 25255287
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.
Venkataswamy MM; Baena A; Goldberg MF; Bricard G; Im JS; Chan J; Reddington F; Besra GS; Jacobs WR; Porcelli SA
J Immunol; 2009 Aug; 183(3):1644-56. PubMed ID: 19620317
[TBL] [Abstract][Full Text] [Related]
3. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
Kawahara M; Matsuo K; Honda M
Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses.
Cayabyab MJ; Korioth-Schmitz B; Sun Y; Carville A; Balachandran H; Miura A; Carlson KR; Buzby AP; Haynes BF; Jacobs WR; Letvin NL
J Virol; 2009 Jun; 83(11):5505-13. PubMed ID: 19297477
[TBL] [Abstract][Full Text] [Related]
5. Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.
Korioth-Schmitz B; Perley CC; Sixsmith JD; Click EM; Lee S; Letvin NL; Frothingham R
Vaccine; 2015 Oct; 33(42):5715-5722. PubMed ID: 26192357
[TBL] [Abstract][Full Text] [Related]
6. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
7. Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.
Kim BJ; Kim BR; Kook YH; Kim BJ
Front Immunol; 2018; 9():643. PubMed ID: 29636755
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques.
Sixsmith JD; Panas MW; Lee S; Gillard GO; White K; Lifton MA; Balachandran H; Mach L; Miller JP; Lavine C; DeMarco CT; Tomaras GD; Gee C; Porcelli SA; Larsen MH; Frothingham R; Schmitz JE; Jacobs WR; Haynes BF; Letvin NL; Korioth-Schmitz B
Clin Vaccine Immunol; 2014 Oct; 21(10):1385-95. PubMed ID: 25080550
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
Kawahara M
Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
[TBL] [Abstract][Full Text] [Related]
10. Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.
Ami Y; Izumi Y; Matsuo K; Someya K; Kanekiyo M; Horibata S; Yoshino N; Sakai K; Shinohara K; Matsumoto S; Yamada T; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Oct; 79(20):12871-9. PubMed ID: 16188989
[TBL] [Abstract][Full Text] [Related]
11. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Mycobacterium bovis BCG producing the N-terminal half of SIVmac251 Env antigen induces neutralizing antibodies and cytotoxic T lymphocyte responses in mice and guinea pigs.
Lim EM; Lagranderie M; Le Grand R; Rauzier J; Gheorghiu M; Gicquel B; Winter N
AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1573-81. PubMed ID: 9430249
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice.
Lagranderie M; Balazuc AM; Gicquel B; Gheorghiu M
J Virol; 1997 Mar; 71(3):2303-9. PubMed ID: 9032366
[TBL] [Abstract][Full Text] [Related]
14. Priming with a recombinant pantothenate auxotroph of Mycobacterium bovis BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells.
Chapman R; Shephard E; Stutz H; Douglass N; Sambandamurthy V; Garcia I; Ryffel B; Jacobs W; Williamson AL
PLoS One; 2012; 7(3):e32769. PubMed ID: 22479338
[TBL] [Abstract][Full Text] [Related]
15. Priming with recombinant auxotrophic BCG expressing HIV-1 Gag, RT and Gp120 and boosting with recombinant MVA induces a robust T cell response in mice.
Chapman R; Stutz H; Jacobs W; Shephard E; Williamson AL
PLoS One; 2013; 8(8):e71601. PubMed ID: 23977084
[TBL] [Abstract][Full Text] [Related]
16. Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses.
Méderlé I; Bourguin I; Ensergueix D; Badell E; Moniz-Peireira J; Gicquel B; Winter N
Infect Immun; 2002 Jan; 70(1):303-14. PubMed ID: 11748196
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
[TBL] [Abstract][Full Text] [Related]
19. Role for Gr-1+ cells in the control of high-dose Mycobacterium bovis recombinant BCG.
Panas MW; Letvin NL
Clin Vaccine Immunol; 2014 Aug; 21(8):1120-7. PubMed ID: 24920602
[TBL] [Abstract][Full Text] [Related]
20. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H
Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
